These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 33408781)

  • 21. Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.
    Cinar B; Yeung F; Konaka H; Mayo MW; Freeman MR; Zhau HE; Chung LW
    Biochem J; 2004 Apr; 379(Pt 2):421-31. PubMed ID: 14715080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.
    Takayama K; Tsutsumi S; Katayama S; Okayama T; Horie-Inoue K; Ikeda K; Urano T; Kawazu C; Hasegawa A; Ikeo K; Gojyobori T; Ouchi Y; Hayashizaki Y; Aburatani H; Inoue S
    Oncogene; 2011 Feb; 30(5):619-30. PubMed ID: 20890304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additional evidence of HS5-1 enhancer eRNA PEARL for protocadherin alpha gene regulation.
    Xu SY; Shou J; Wu Q
    Yi Chuan; 2022 Aug; 44(8):695-764. PubMed ID: 36384668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer.
    Ding M; Jiang CY; Zhang Y; Zhao J; Han BM; Xia SJ
    J Exp Clin Cancer Res; 2020 Feb; 39(1):28. PubMed ID: 32019578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets.
    Toropainen S; Niskanen EA; Malinen M; Sutinen P; Kaikkonen MU; Palvimo JJ
    Sci Rep; 2016 Sep; 6():33510. PubMed ID: 27641228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of aberrantly methylated androgen receptor target gene PCDH7 on the development of androgen-independent prostate cancer cells.
    Xu S; Wu X; Tao Z; Li H; Fan C; Chen S; Guo J; Ning Y; Hu X
    Genes Genomics; 2020 Mar; 42(3):299-307. PubMed ID: 31872382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3.
    Zhou L; Song Z; Hu J; Liu L; Hou Y; Zhang X; Yang X; Chen K
    Theranostics; 2021; 11(2):841-860. PubMed ID: 33391508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
    Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
    Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
    [No Abstract]   [Full Text] [Related]  

  • 29. GAS1RR, an immune-related enhancer RNA, is related to biochemical recurrence-free survival in prostate cancer.
    Xiong Z; Ge Y; Xiao J; Wang Y; Li L; Ma S; Lan L; Liu B; Qin B; Luan Y; Yang C; Ye Z; Wang Z
    Exp Biol Med (Maywood); 2023 Jan; 248(1):1-13. PubMed ID: 36408742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SMYD3 as an oncogenic driver in prostate cancer by stimulation of androgen receptor transcription.
    Liu C; Wang C; Wang K; Liu L; Shen Q; Yan K; Sun X; Chen J; Liu J; Ren H; Liu H; Xu Z; Hu S; Xu D; Fan Y
    J Natl Cancer Inst; 2013 Nov; 105(22):1719-28. PubMed ID: 24174655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression.
    Chou FJ; Chen Y; Chen D; Niu Y; Li G; Keng P; Yeh S; Chang C
    EBioMedicine; 2019 Feb; 40():504-516. PubMed ID: 30692044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancer RNA: biogenesis, function, and regulation.
    Ye R; Cao C; Xue Y
    Essays Biochem; 2020 Dec; 64(6):883-894. PubMed ID: 33034351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential.
    Lee JH; Xiong F; Li W
    RNA Biol; 2020 Nov; 17(11):1550-1559. PubMed ID: 31916476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel transcriptional network for the androgen receptor in human epididymis epithelial cells.
    Yang R; Browne JA; Eggener SE; Leir SH; Harris A
    Mol Hum Reprod; 2018 Sep; 24(9):433-443. PubMed ID: 30016502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High OGT activity is essential for MYC-driven proliferation of prostate cancer cells.
    Itkonen HM; Urbanucci A; Martin SE; Khan A; Mathelier A; Thiede B; Walker S; Mills IG
    Theranostics; 2019; 9(8):2183-2197. PubMed ID: 31149037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
    Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides.
    Eder IE; Culig Z; Ramoner R; Thurnher M; Putz T; Nessler-Menardi C; Tiefenthaler M; Bartsch G; Klocker H
    Cancer Gene Ther; 2000 Jul; 7(7):997-1007. PubMed ID: 10917202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic Functional Interrogation of Genes in GWAS Loci Identified ATF1 as a Key Driver in Colorectal Cancer Modulated by a Promoter-Enhancer Interaction.
    Tian J; Chang J; Gong J; Lou J; Fu M; Li J; Ke J; Zhu Y; Gong Y; Yang Y; Zou D; Peng X; Yang N; Mei S; Wang X; Zhong R; Cai K; Miao X
    Am J Hum Genet; 2019 Jul; 105(1):29-47. PubMed ID: 31204011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methyltransferase inhibitor adenosine dialdehyde suppresses androgen receptor expression and prostate cancer growth.
    Shiota M; Takeuchi A; Yokomizo A; Kashiwagi E; Tatsugami K; Naito S
    J Urol; 2012 Jul; 188(1):300-6. PubMed ID: 22608750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A High-Resolution Map of Human Enhancer RNA Loci Characterizes Super-enhancer Activities in Cancer.
    Chen H; Liang H
    Cancer Cell; 2020 Nov; 38(5):701-715.e5. PubMed ID: 33007258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.